Human Umbilical Cord Mesenchymal Stem Cell therapy (Changchun Tuohua Pharmaceutical)

N/A

Report date: 2026/02/25 20:02:36

Base Information

Drug NameHuman Umbilical Cord Mesenchymal Stem Cell therapy (Changchun Tuohua Pharmaceutical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChangchun Tuohua Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Tuohua Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A